The Quantra® System from HemoSonics Earns Best Instrument Honors at 85th Annual AAST Meeting

Attendee-voted recognition highlights the Quantra System’s relevance to trauma care.

DURHAM, N.C.--(BUSINESS WIRE)--HemoSonics, LLC announced that its Quantra^® System was named Best Instrument at the 85th Annual Meeting of the American Association for the Surgery of Trauma (AAST) and Clinical Congress of Acute Care Surgery, held September 16–19 in Dallas, TX. The award was voted on by meeting attendees, including clinicians and trauma surgeons.

Shylah Quast, BSN, RN, Director of Clinical Excellence, and Davis Bland, Business Development & Strategic Partnerships, accepted the award on behalf of HemoSonics.

“Trauma care is an important focus for HemoSonics because major bleeding remains a significant contributor to poor outcomes following traumatic injury,” said Davis Bland. “Timely information can help clinicians make informed decisions about bleeding management, and we’re proud to see the Quantra System recognized by the clinicians and trauma surgeons working to improve care for these patients.”

The Quantra System is a cartridge-based, point-of-care viscoelastic testing (VET) platform that uses ultrasound-based technology to assess whole-blood coagulation. In trauma care, VET can provide information about clot formation, clot strength, and clot breakdown to help clinicians guide bleeding management.

International clinical guidance and professional societies have recognized the role of viscoelastic testing in supporting the assessment and treatment of bleeding. HemoSonics remains committed to advancing access to timely coagulation information and supporting clinicians as they navigate complex, time-sensitive decisions in trauma care.

The 85th Annual AAST Meeting brought together 993 physicians and scientists and featured over 50 exhibitors, providing a forum for clinical research, education and collaboration across trauma and acute care surgery.

About HemoSonics

HemoSonics, LLC is a medical device technology company focused on acute bleeding management, improving patient care, and reducing overall medical costs. The Quantra Hemostasis System, HemoSonics’ flagship product, is designed to improve patient outcomes and reduce healthcare costs by providing optimized coagulation information. The Quantra System’s easy, fast interpretation enables simple, more efficient bleeding management at the point of care and in the laboratory.

Based in Durham, N.C., HemoSonics is part of the Stago Group, a leading in vitro diagnostics company dedicated to advancing research in thrombosis and hemostasis. Follow HemoSonics on LinkedIn or visit HemoSonics.com to learn more.